Aug
20

Immigrants in the workforce – and implications thereof

One of every seven workers in the US is foreign-born.

About half are Hispanic and a quarter Asian.  About a third of the foreign born workers are undocumented.

We’ll leave aside the problems with immigration regulation, drivers thereof, lazy Americans, and all the rest of the and focus on the impact of these foreign-born folks on workers’ comp.

Today’s WorkCompWire features a piece by friend and colleague Peter Rousmaniere on the subject; Peter’s been tracking this very closely for years, and is the most knowledgeable person I know on the subject.  Here’s a key passage:

When you estimate the number of future work injuries, taking into account the injury rates of the individual jobs and their expected growth of openings, you find that immigrant workers will likely sustain 20% — one of every five – of work injuries. (emphasis added)

Here are just a few of the implications I see; as the acknowledged expert Peter’s got a much deeper and broader perspective.

  • Most of these workers likely won’t know much about the US health care system or workers’ comp, and will get that information from people they know and trust – their fellow countrymen.
  • Many may not have primary care physicians, so will seek care at the most convenient/nearest location.
  • The language issues are both obvious and subtle; even those with passable English skills may not fully grasp what they’re hearing and reading, leading to mis-interpretations and misunderstanding.

With the share of jobs held by first-generation immigrants going to increase steadily for the foreseeable future, payers and service companies alike are going to have to alter their practices to accommodate an evolving workforce.

What does this mean for you?

Recognizing the reality will be much more productive than ranting about it.


Aug
15

Highlights of the Survey of Drug Management in Work Comp – 2013 edition

Payers’ views of drug management in workers’ comp have evolved dramatically over the last decade; here are a few initial takeaways from the 10th Annual Survey of Prescription Drug Management in Worker’s Compensation.

  • For the third consecutive year, respondents’ drug costs declined in real terms, both for the average across all respondents (-3.9%) and the average of each respondent (-3.7%).
  • On a scale of 1 through 5 with 3 being “drug costs are equally as important as other medical cost issues,” drug costs were rated a 3.9, or “more important than other medical cost issues.”

  • Respondents are concerned (4.0) that drug costs will be more of a problem in the next 12-24 months than they are today.

  • Respondents deemed opioid prescribing, dispensing, monitoring, and management as the most important way to control workers’ compensation pharmacy costs. Respondents judged opioids to be an extremely significant problem, giving it an average of 4.8. This remains the highest score for any survey question in the history of the survey
  • All but one respondents had made significant upgrades and improvements to their clinical programs in 2012 

We’ve been surveying workers’ comp payers about their views on prescription drug management for ten years now, and the results from this year’s Survey show a remarkable increase in respondents’ expertise, depth of knowledge, and level of sophistication.  The responses to qualitative questions revealed most respondents are far more familiar with all aspects of the drug issue than they were a decade ago.

It is no surprise, then, that costs have declined over the last few years.  While there have undoubtedly been external factors that have contributed to that happy event, there’s also no question that the payers’ focus on this issue is paying off – in lower costs, better care, and reduced premiums.

That said, the looming opioid crisis will require a redoubling of that focus if payers are going to avoid the potentially devastating long-term financial consequences of opioid usage.

Past surveys are available here; a public version of the 2013 Survey will be available next week; I’ll let you know when it is.


Aug
14

Survey – Opioids and Workers’ Compensation

It is NO secret that opioids are an issue for the workers’ compensation industry – the cost of the average lost-time claim with long acting opioids 900% higher than those without.

What is a secret is why there’s a picture of an iPad Mini here (see last paragraph for details)…

iPad_mini_MQ

We do know (thanks to a story published in The New York Times’ June 22, 2013 entitled “The Soaring Cost Of the Opioid Economy,”) the stronger the opioid, the higher the expense of the claim as:

  • the average cost of claims without opioids is $13,000;
  • the average cost with a short-acting opioid e.g. Percocet is $39,000 (300% of avg.);
  • the average cost with a long-acting opioid e.g. OxyContin is $117,000 (900% of avg.); and,
  • between 2001 and 2008, narcotics prescriptions as a share of all drugs used to treat workplace injuries jumped 63 percent, according to insurance industry data.

The claims cost while enormous seems small in comparison to the human toll that opioids are taking on families and friends. Opioids are highly addictive and are robbing users of their lives as they knew them and by taking them:

·      U.S. EMERGENCY ROOM COSTS Cases in which an opioid other than heroin was cited as a reason for an emergency-room treatment in 2004 – 299,498 and in 2011 – 885,348 (almost a 300% increase).

·      OVERDOSE DEATHS Where prescription opioids were involved in 1999 – 4,030 and in 2010 – 16,651 (over a 400% increase).

·      DRUGS FOR OPIOID ADDICTION The number of prescriptions dispensed for two drugs increasingly given to treat opioid addiction — buprenorphine and naltrexone — has soared along with opioid use from almost zero in 2002 to 8 million prescriptions in 2012.

·      PATIENTS IN ADDICTION TREATMENT Number of patients in a one-day survey at facilities that use methadone or buprenorphine to treat addiction to pain pills or heroin has risen from 228,140 in 2002 to 313,460 in 2011. (Does not include all patients treated at doctors’ offices.)

What we don’t know is payers’ perceptions, programs, and results.  To that end, we are conducting an online Survey of Opioids and Workers’ Compensation; seeking information about what payers think and are doing about opioids; how opioids are affecting loss costs, claims handling, and claim closure; what management programs are working and what aren’t; the role of the adjuster and PBM; what role opioids should play in worker’s comp; and what the future holds.

Click here to complete the Survey

Couple details –

  • all survey respondents get a detailed copy of the Survey Report
  • one respondent will get a16Gb iPad Mini in the color of her/his choice
  • all responses are confidential

Aug
1

Lousy back pain care – it’s not just work comp

What’s changed in treating back pain over the last decade?

More narcotics and fewer NSAIDs.  More referrals to specialists, less treatment by primary care docs.  More MRIs and CTs.  

A really illuminating article just published in JAMA provided those insights and more, concluding “Despite numerous published clinical guidelines, management of back pain has relied increasingly on guideline discordant care.”

Like 29% of patients prescribed narcotics.

In other words, more care, delivered by more expensive providers, with higher risks, despite no evidence it improves results.

Not only do we have a looooong way to go, it’s getting longer every day…

 


Jul
11

Dispensing docs to Hippocrates: Drop Dead.

That’s the only conclusion one can reach after reading WCRI’s latest report, The Impact of Banning Physician Dispensing of Opioids in Florida.

Here’s why.

As of July 1, 2011, Florida’s docs could no longer dispense most opioids from their offices.  Before that date, 5.7% of the scripts dispensed by docs were opioids that fell under the ban.

After?  0.6%, and almost all of those were dispensed by docs outside of FL for FL claimants.

Well, we’d expect the volume of pharmacy-dispensed opioids to go up dramatically, wouldn’t we?  After all, no physician would ever prescribe opioids to a patient who absolutely didn’t need them, right?

Wrong.

The volume of pharmacy-dispensed opioids declined.  Went down.  Decreased.

In fact, 3.5% of patients were receiving the stronger opioids from docs before the ban, only 0.5% after (again these were mostly from cross-border trips by FL claimants to out-of-state dispensing physicians).  And the percentage of claimants getting stronger opioids from pharmacies went up by a mere one-tenth of one percent.

Conclusion?

Dispensing docs were prescribing and dispensing strong opioids to many patients who DID NOT NEED THEM.  Why?  For the money.

Opioids are incredibly dangerous.  Opioids kill people.  Destroy families.  Ruin lives.  Addict children.  An intelligent, articulate, promising young woman I know is now a prostitute, selling herself to strangers because she became addicted to prescription drugs.  Her family is devastated, her dreams reduced to the next high.

And these money-grubbing bastards allow this to happen, just to make money to buy nicer cars, better wines, fancier dinners.  

What does this mean for you?

STOP ALLOWING ANY PHYSICIAN DISPENSING.


Jul
10

Obamacare and workers’ comp – part 4 of 9; cost shifting

After a brief diversion yesterday to focus on breaking news and research, it’s back to the impact of health reform on comp, with today’s post delving in to cost-shifting.

Cost-shifting is a general term for provider behavior involving seeking more revenue from some patients/payers to make up for lower/insufficient revenue from others.  The term itself is not without controversy, but we’ll set aside semantics and focus on a simple question – will Obamacare lead to higher costs for comp payers as providers seek to make up for lower/lost revenue from other sources.

The short answer is – probably not.

The longer answer is this – more reimbursed patient car leads to less motivation to cost shift, and although many of the newly insured will be low-reimbursing Medicaid patients getting 85% of cost is a lot better than 11%.  Therefore, if anything Obamacare’s broader coverage will reduce the motivation to cost-shift.

The detailed answer follows…

Providers, particularly hospitals (which account for about a third of all WC medical costs) have to provide emergent care to patients without insurance.  Currently there are about 50 million folks without insurance in the US; post reform there will be about 20 million (estimates will vary, but regardless there will be a LOT fewer uninsureds).

Logic implies that more paying patients is better than fewer, and more providers will get paid for more patient care next year than this, leading to less motivation for those providers to shift costs to their workers’ comp patients.  The key word here is “motivation”; just because there’s less rationale for cost-shifting does NOT mean providers will suddenly decide to stop charging higher fees and doing more for their comp patients.  I’d also note that it is unlikely that most providers consciously decide to alter their treatment based on their patient’s reimbursement.

However, this being workers’ comp and health care, logic doesn’t necessarily apply.  Here are a couple things to consider.

First, a just-published analysis of the impact of lower Medicare reimbursement rates on private payer costs found:

“a 10 percent reduction in Medicare payment rates led to an estimated reduction in private payment rates of 3 percent or 8 percent, depending on the statistical model used. These payment rate spillovers may reflect an effort by hospitals to rein in their operating costs in the face of lower Medicare payment rates. Alternatively, hospitals facing cuts in Medicare payment rates may also cut the payment rates they seek from private payers to attract more privately insured patients.”

The analysis was based on hospital data from 1995 to 2009, a period during which Medicare hospital reimbursement was increasing quite modestly.  Of course, workers’ comp was not considered nor WC reimbursement analyzed by the study’s author, so we are left with more questions than answers.

It is also important to note that almost the entire study period was before anyone had even contemplated health reform and the dramatic impact on hospital reimbursement that will follow.  The world has changed dramatically, and this historical perspective may no longer provide much in the way of insight into future behaviors. 

Second, private payers have a LOT more bargaining power than work comp payers and network developers; WC insurers are already seeing significantly higher facility costs (anecdotal information from HSA consulting clients). And these higher costs are coming on top of research clearly indicating comp pays a lot more for hospital services than private insurers (see results of WCRI research on outpatient hospital costs).  So, comp already pays more, and until and unless networks and insurers figure out ways to better control utilization and price, they are going to continue to pay more.

Here’s what this means for you.

Third, some comp payers are beginning to figure out which hospitals are screwing them, and which are not, and doing whatever they can to direct away from the high cost facilities and to the low cost/high outcome providers.  Cost shifting will continue, but these smart payers will mitigate its impact while their less-smart competitors will wonder why their medical expenses are rapidly escalating.

 


Jul
9

Why do docs dispense meds to work comp patients?

Yesterday’s  WCRI report on physician dispensing in Georgia post-reform is stuffed with insights into physician behavior and motivators thereof.

In April 2011, the Peach State capped the price of physician-dispensed repackaged drugs at the AWP of the original, non-repackaged drug, thereby eliminating the outrageous markups the docs and their enablers were charging employers and taxpayers.  WCRI examined prescribing behavior pre- and post-reform; here’s my take on the more interesting results;

  • Post-reform, drugs dispensed by docs were still substantially more expensive than the same pills from a pharmacy.
  • Dispensing docs are more likely than non-dispensing physicians to write scripts for Tylenol, ibuprofen, Aleve, and Prilosec – drugs that can be bought cheaply over the counter.
  • Prescribing patterns among dispensing docs changed post-reform to include more expensive versions of similar drugs
  • After reform, drugs dispensed by docs cost 20 – 40 percent more than the same drug bought at a pharmacy; likely because almost all payers use a PBM, which provides the payer with a big discount on drugs bought at a pharmacy. WCRI: “Because pharmacy benefit managers (PBMs) often contract with pharmacies for discounted prices below AWP, it would not be surprising to see that the pharmacy prices were, on average, lower than the prices paid to physician-dispensers for the same drug.”
  • As in California post-reform, the price cut by eliminating the up-charge for repackaged drugs did not significantly reduce dispensing; 35% of scripts were dispensed by docs before reform, 28 percent after.

So, what can we surmise from the data.  I’d suggest several one things.

  1. Dispensing docs do it for the money.  Duh. 

Despite all the BS about patient care, outcomes, convenience, and access, they do it for the dollars.

Here’s proof.


Jul
3

Obamacare and workers’ comp – Part 2 of 9

Monday we kicked off the discussion of the impact of PPACA/Obamacare/health reform on workers’ comp with a review of the (very limited) direct impact of reform on comp.  Today it’s the the impact of increased group and Medicaid insurance coverage on workers’ comp.

Let’s leave aside yesterday’s announcement by HHS that the employer mandate will be delayed till 2015; we’re after the long-term impact, so the one year delay will not be material to our discussion.  There will be somewhere around 30 million more folks covered by health insurance post implementation, with 32% covered under Medicaid, 45% from the individual exchanges, and 23% from employers.  Here are the major effects of the increased coverage…

  • Healthier workers heal fasterpeople without health insurance are not as healthy as those with coverage, and as healthier people heal more quickly when they are injured, the increased coverage means more work comp claimants will heal more quickly – reducing medical cost and indemnity expense.

  • The preventive benefits will help identify – and hopefully lead to early treatment for – health issues that can prolong/delay recovery.  Diabetes, asthma, depression, hypertension, and other conditions often go undetected until something really bad happens – an acute episode requiring a visit to the ER is typical.  Controlling these conditions and keeping them under control will speed recovery from injuries.
  • Many injured workers don’t have health insurance. If they have health conditions – say obesity – that are affecting recovery from an injury, the comp payer often ends up paying to treat that condition as well as the occupational injury.  If the diabetic injured worker does have health insurance, the comp payer doesn’t have to pay to treat the diabetes – a key consideration as the condition can dramatically affect recovery from surgery.
  • There appears to be a correlation between the availability of health insurance and claim filing, but it isn’t what many think.  A 2005 RAND paper notes “uninsured and more vulnerable workers are actually less likely to file claims than the insured.” Why?

“even repeat injury-sufferers are more likely to file during episodes in which their employer offers health insurance, but not statistically more likely to file during episodes in which they themselves are insured. This suggests that the workplace environment and employer incentives may have a significant, or perhaps even the dominant, impact on workers’ compensation filing.”

Next week — more on the impact of PPACA – bet you can’t wait!

 


Jun
27

Should workers’ comp pay more for medical care than group health?

That is the question I’m left with after reading WCRI’s latest reports.

One compares group health’s payments for outpatient hospital services to work comp’s; the other discusses the use of group health payments as the basis for a work comp provider fee schedule.  There is a wealth of insight in both studies; generally, states with fee schedules had lower work comp medical costs than those without

The latter is the subject of today’s post; it “focuses on the median nonhospital price paid for five common surgeries and four common established patient office visits in 22 large states for services delivered in 2009.”; it compares group payments to comp.  By focusing on actual prices paid, the analysis factors in network and other discounts taken, increasing the “validity” of the data.

I’ve long thought providers should get paid more for care delivered to workers comp patients than for group, medicare, or medicaid.  Comp involves disability management and all the communications, reporting, and complications inherent in considering disability in delivering care, and as we expect physicians and other care givers to take an active role in that process, by rights we should expect to pay them for that additional work.

That said, the dichotomy between pricing differentials for office visits vs. surgeries reported by WCRI strikes me as precisely the opposite of what should be.  Specifically, the prices paid for office visits under group and comp were typically within 30 percent, with a range of 15 percent in about half of the states studied; in several states comp paid significantly less than group for office visits. Office visits are where and when the “disability management’ stuff occurs as the physician discusses the return to work plan, engages with the field case manager (if one is involved), talks with the claimant about the claimant’s job functions, physical capabilities and limitations, and other factors affecting disability.  This takes time, thought, documentation, expertise.

Conversely, reimbursement for surgeries was generally much higher when the payer was workers’ comp than when a health plan was on the hook. Remember, the payment is specific to the surgical procedure; it does not include visits pre- and post-surgery. A knee arthroscopy is a knee arthroscopy; yes, there may be a little different documentation for WC surgeries, but the surgical notes should consider functionality, rehab plans, and prognosis regardless of who the payer is. Yet in only one state – Michigan – was the reimbursement essentially identical, while in the other 21 states, the reimbursement was higher for comp – in seven states comp reimbursed at least twice as much as group health. 

Surgeons may argue that the higher reimbursement is necessary to ensure access; that argument, should it be made, is easily addressed by noting physicians are willing to accept much lower reimbursement for the identical procedure for most of their patients; there’s no access problem for group health patients despite the lower reimbursement.

In contrast, reimbursement for office visits should be higher for workers’ comp, for the reasons noted above.  If not for the office visit code itself, than perhaps states should institute a different code for disability management (some payers already do this).

What does this mean for you?

From here, this looks like another example of under-valuing primary care and patient – physician interaction, while over-valuing procedures; doing stuff TO patients.  


Jun
26

Immigrants and health care – who’s paying, who’s getting

Immigrants Contributed An Estimated $115.2 Billion More To The Medicare Trust Fund Than They Took Out In 2002–09 – that’s the headline from a piece in Health Affairs this month.

“immigrants may be disproportionately subsidizing the Medicare Trust Fund, which supports payments to hospitals and institutions…In 2009 immigrants made 14.7 percent of Trust Fund contributions but accounted for only 7.9 percent of its expenditures—a net surplus of $13.8 billion. In contrast, US-born people generated a $30.9 billion deficit…

Most of the surplus from immigrants was contributed by noncitizens [emphasis added] and was a result of the high proportion of working-age taxpayers in this group. Policies that restrict immigration may deplete Medicare’s financial resources.”

When one considers that birth rates among citizens are declining, and thus there will be fewer young working folks to support us aged people, the current anti-immigrant/nativist stance starts to look a little problematic.

Fact is, Medicare and Social Security depend on contributions from working age people; if we drastically restrict immigration and deport all undocumented aliens those two programs will be in dire financial straits much sooner than anticipated.

Conversely, a more “open” policy would go a long way toward reducing the strain on Medicare and SS.

Just saying.